New TB Vaccine for Adolescents, Adults Ready for Commercialisation
The vaccine targets pulmonary tuberculosis in adolescents and adults and aims to boost existing BCG vaccine efficacy, with phase I and II trials planned within five years.
8 Articles
8 Articles
IIT Bhubaneswar & ILS Transfer Next-Gen TB Vaccine Technology To TechInvention
Bhubaneswar: A quadripartite license agreement (QLA) was signed for the technology transfer and future commercialisation of a novel tuberculosis (TB) vaccine candidate titled ‘HSP Subunit Vaccine in Adjuvant (DDA) Against Mycobacterium tuberculosis’. The agreement was signed by the Indian Institute of Technology (IIT) Bhubaneswar, Institute of Life Sciences (ILS), Bhubaneswar and the National Research Development Corporation (NRDC) with TechInve…
IIT Bhubaneswar signs agreement for TB vaccine
Bhubaneswar: Taking a major stride toward advancing indigenous TB vaccine research, IIT Bhubaneswar, the Institute of Life Sciences (ILS), and the National Research Development Corporation (NRDC) have formalised a Quadripartite License Agreement with TechInvention Lifecare Limited. The agreement paves the way for technology transfer and potential commercialisation of a promising new vaccine candidate, “HSP Subunit Vaccine in Adjuvant (DDA) Agai…
Odisha: IIT Bhubaneswar signs agreement for Novel TB vaccine technology
Bhubaneswar, Nov 24 (IANS) Taking a major stride toward advancing indigenous TB vaccine research, IIT Bhubaneswar, the Institute of Life Sciences (ILS), and the National Research Development Corporation (NRDC) have… Continue reading Odisha: IIT Bhubaneswar signs agreement for Novel TB vaccine technology The post Odisha: IIT Bhubaneswar signs agreement for Novel TB vaccine technology first appeared on Australia India News.
Coverage Details
Bias Distribution
- 67% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium



